Anavex Life Sciences Corp. appointed Claus van der Velden to its board of directors.
Van der Velden is Ströer SE & Co. KGaA's corporate head of management accounting, internal audit and risk management.
Anavex is a New York-based biopharmaceutical company developing treatments for neurological diseases.
